Smoking reduction interventions for smoking cessation.

Area of Science:

• Public Health
• Addiction Medicine
• Behavioral Science

Background:

• Standard smoking cessation advice often emphasizes abrupt quitting on a set date.
• Individuals attempting to quit smoking may seek alternative methods beyond abrupt cessation.
• Reducing smoking behavior prior to quitting is a potential alternative cessation strategy.

Purpose of the Study:

• To evaluate the effectiveness of reduction-to-quit interventions for long-term smoking cessation.
• To compare reduction-to-quit strategies against abrupt quitting and no treatment interventions.
• To identify factors that may optimize reduction-to-quit methods for enhanced success rates.

Main Methods:

• Systematic review and meta-analysis of 51 randomized controlled trials (RCTs) involving 22,509 participants.
• Studies compared reduction-to-quit interventions with no treatment, abrupt quitting, or other reduction strategies.
• Long-term smoking cessation was assessed at a minimum of six months follow-up.

Main Results:

• Reduction-to-quit interventions showed no significant difference in long-term quit rates compared to abrupt quitting (moderate certainty evidence).
• Evidence comparing reduction-to-quit to no treatment was inconclusive (low certainty).
• Pharmacotherapy, particularly varenicline or fast-acting nicotine replacement therapy (NRT), appeared to enhance quit rates when used with reduction strategies (moderate certainty).

Conclusions:

• Neither reduction-to-quit nor abrupt quitting strategies demonstrate superior long-term smoking cessation rates.
• Pharmacotherapy-assisted reduction-to-quit interventions show promise, especially with varenicline or fast-acting NRT.
• Further high-quality research is recommended to isolate the effects of reduction strategies and optimize their implementation.